Lei Z. Zheng
Experienced in Myeloproliferative Neoplasms (MPN)

Lei Z. Zheng

No. 639 Zhizaoju Road, 
Huangpu, CN 
Experienced in Myeloproliferative Neoplasms (MPN)
No. 639 Zhizaoju Road, 
Huangpu, CN 
OverviewLocationsClinical Research

Overview

Lei Zheng practices in Huangpu, China. Ms. Zheng is rated as an Experienced expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Portal Hypertension, Pancreaticoduodenectomy, and Pancreatectomy.

Her clinical research consists of co-authoring 1405 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Myeloproliferative Neoplasms (MPN).

Gender
Female

Locations

No. 639 Zhizaoju Road, Huangpu, 200011, China
Other Locations
Zhongshan Road 321, Nanjing, 210008, China
No.1838 North Guangzhou Avenue, Guangzhou, 510515, China
No. 258, Wenhua Road, Qinhuangdao, 066000, China
No. 197, Ruijin No.2 Road, Huangpu, China
38 Guangji Road, Hangzhou, 310022, China
No. 62 Weiyu Road, Liaocheng, 252000, China
No. 3333 Binsheng Road, Hangzhou, China
P.O. Box 69 Branch 13, Xi'an, 710024, China
No. 3333 Binsheng Road, Hangzhou, 310052, China
51 Fucheng Road, Beijing, 100048, China
Chinese Academy Of Tropical Agricultural Sciences Guangzhou Experimental Station, Guangzhou, 510140, China
180 Ren Min East Road, Hengshui, 053000, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase I/II Trial of Combination Immunotherapy With Nivolumab and a CCR2/CCR5 Dual Antagonist (BMS-813160) With or Without GVAX Following Chemotherapy and Radiotherapy for Locally Advanced Pancreatic Ductal Adenocarcinomas (PDACs).
A Phase I/II Trial of Combination Immunotherapy With Nivolumab and a CCR2/CCR5 Dual Antagonist (BMS-813160) With or Without GVAX Following Chemotherapy and Radiotherapy for Locally Advanced Pancreatic Ductal Adenocarcinomas (PDACs).
Enrollment Status: Completed
Publish Date: September 23, 2025
Intervention Type: Drug, Radiation
Study Drugs: Nivolumab, CCR2/CCR5 dual antagonist, GVAX
Study Phase: Phase 1/Phase 2
A Safety and Feasibility Trial of Boost Vaccinations of a Lethally Irradiated, Allogeneic Pancreatic Tumor Cell Vaccine Transfected With the GM-CSF Gene Given Alone or in Combination With Either a Single Intravenous Dose or Daily Metronomic Oral Doses of Cyclophosphamide for the Treatment of Surgically Resected Pancreatic Adenocarcinoma
A Safety and Feasibility Trial of Boost Vaccinations of a Lethally Irradiated, Allogeneic Pancreatic Tumor Cell Vaccine Transfected With the GM-CSF Gene Given Alone or in Combination With Either a Single Intravenous Dose or Daily Metronomic Oral Doses of Cyclophosphamide for the Treatment of Surgically Resected Pancreatic Adenocarcinoma
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2025
Intervention Type: Biological, Drug
Study Drug: PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine
Study Phase: Phase 2
A Platform Study of Combination Immunotherapy for the Neoadjuvant and Adjuvant Treatment of Patients With Surgically Resectable Adenocarcinoma of the Pancreas
A Platform Study of Combination Immunotherapy for the Neoadjuvant and Adjuvant Treatment of Patients With Surgically Resectable Adenocarcinoma of the Pancreas
Enrollment Status: Active_not_recruiting
Publish Date: July 20, 2025
Intervention Type: Drug, Biological
Study Drugs: Cyclophosphamide, GVAX pancreatic cancer, Nivolumab, Urelumab
Study Phase: Phase 2
Phase II Study to Evaluate Stereotactic Body Radiation Therapy For Palliative Management of Unresectable Recurrent or Residual Pancreatic or Periampullary Adenocarcinoma
Phase II Study to Evaluate Stereotactic Body Radiation Therapy For Palliative Management of Unresectable Recurrent or Residual Pancreatic or Periampullary Adenocarcinoma
Enrollment Status: Completed
Publish Date: July 20, 2025
Intervention Type: Radiation
Study Phase: Phase 2
A Multicenter, Single-blind, Pair-matched, Observational Clinical Trial of LUNSAFE
A Multicenter, Single-blind, Pair-matched, Observational Clinical Trial of LUNSAFE
Enrollment Status: Completed
Publish Date: March 21, 2025
Intervention Type: Diagnostic test, Procedure
A Phase II Study of GM-CSF Secreting Allogeneic Pancreatic Cancer Vaccine in Combination With PD-1 Blockade Antibody (Pembrolizumab) and Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients With Locally Advanced Adenocarcinoma of the Pancreas
A Phase II Study of GM-CSF Secreting Allogeneic Pancreatic Cancer Vaccine in Combination With PD-1 Blockade Antibody (Pembrolizumab) and Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients With Locally Advanced Adenocarcinoma of the Pancreas
Enrollment Status: Completed
Publish Date: September 05, 2024
Intervention Type: Radiation, Drug
Study Drugs: Cyclophosphamide, GVAX, Pembrolizumab
Study Phase: Phase 2
View 5 Less Clinical Trials

1403 Total Publications

Low Wall Shear Stress Promotes Atheroma via Arterial Iron Accumulation.
Low Wall Shear Stress Promotes Atheroma via Arterial Iron Accumulation.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: October 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Zheng's expertise for a condition
ConditionClose
    View All 17 Advanced Conditions
    View All 164 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile